Novalis Biotech holds first closing of second healthcare fund
Novalis Biotech, an early stage venture capital investor in healthcare, technologies has held the first closing of its second fund, Novalis Biotech Acceleration, raising an initial EUR8 million. With commitments for a similar amount already in place, Novalis anticipates a final closing in early 2021. The majority of investors in